Drug Trial Radar · NCT06229210
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Jan 25, 2024
Primary completion
Apr 28, 2032
Study completion Apr 28, 2032
Sponsor
- Lead sponsor
- Intra-Cellular Therapies, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 5 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar disorder or autism spectrum disorder.
Conditions
- Schizophrenia
- Bipolar Disorder
- Autism Spectrum Disorder
Interventions
LumateperoneDrug
Lumateperone 5 mg - 42 mg capsules or orally disintegrating tablets administered orally, once daily based on age and indication
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Common Adverse EventsTime frame: Up to 6 months
Locations
65 sites in 3 countries. Site status is shown where the registry gives one.
Southwest Autism Research and Resource Center
Phoenix, Arizona · Recruiting
Pillar Clinical Research, LLC
Little Rock, Arkansas · Recruiting
Advanced Research Center, Inc
Anaheim, California · Recruiting
National Institute Of Clinical Research
Garden Grove, California · Recruiting
Excell Research Inc
Oceanside, California · Recruiting
Inland Psychiatric Medical Group Inc
Redlands, California · Recruiting
University Of California - Davis
Sacramento, California · Recruiting
University Of California San Diego
San Diego, California · Completed
Next Level Clinical Trials, LLC
West Covina, California · Recruiting
MCB Clinical Research Centers LLC
Colorado Springs, Colorado · Completed
Royal Palm Clinical Research
Fort Myers, Florida · Suspended
Sarkis Clinical Trials
Gainesville, Florida · Recruiting
United Research Institute
Hialeah, Florida · Recruiting
Advanced Research Institute of Miami
Homestead, Florida · Recruiting
Green Leaf Clinical Trials
Jacksonville, Florida · Recruiting
Vital Care Research
Miami, Florida · Suspended
Columbus Clinical Services LLC
Miami, Florida · Recruiting
Care Research Center Inc
Miami, Florida · Recruiting
Blue Medical Research
Miami, Florida · Recruiting
AP Medical Research
Miami, Florida · Suspended
Envision Trials LLC
Miami, Florida · Recruiting
GTL Medical and Research Group
Miami, Florida · Completed
Diverse Clinical Research LLC
Miami, Florida · Recruiting
Links Clinical Trials
Miami, Florida · Recruiting
New Med Research Inc
Miami Gardens, Florida · Recruiting
The Angel Medical Research Corporation
Miami Gardens, Florida · Recruiting
Riveldi Biomedical Research
Miami Lakes, Florida · Recruiting
APG Research LLC
Orlando, Florida · Suspended
Clinical Research Center of Florida
Pompano Beach, Florida · Recruiting
University of South Florida Rothman Center of Neuropsychiatry
St. Petersburg, Florida · Recruiting
Health Synergy Clinical Research
West Palm Beach, Florida · Recruiting
CenExeli Research LLC
Atlanta, Georgia · Recruiting
Atlanta Center for Medical Research
Atlanta, Georgia · Recruiting
Atlanta Behavioral Research, LLC
Atlanta, Georgia · Completed
Salveo Integrative Health Inc
Lawrenceville, Georgia · Completed
CenExeli Research LLC 1
Savannah, Georgia · Recruiting
Baber Research Group
Naperville, Illinois · Recruiting
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana · Completed
Neurobehavioral Medicine Group
Bloomfield Hills, Michigan · Recruiting
Midwest Research Group 1
Saint Charles, Missouri · Recruiting
Showing 40 of 65 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.